Oussama Abla, MD
Expert Physician
Juvenile Xanthogranuloma (JXG)
Dr Oussama Abla is a Professor of Pediatrics at the University of Toronto and a pediatric oncologist at the Hospital for Sick Children in Toronto, Canada. He is the Founder and Director of the Pediatric Histiocytosis Program, Director of the Histiocytosis Fellowship Program, Chair of the International Histiocytosis Clinical Rounds, and a member of the Leukemia/Lymphoma section at the Hospital for Sick Children.
His clinical and research interests focus on better understanding of the biology and treatment of of Rare Histiocytic Disorders (RHD), pediatric Langerhans cell Histiocytosis (LCH), acute promyelocytic leukemia (APL) and rare childhood non-Hodgkin’s Lymphomas. He is the Co-Editor of the “Supportive Care in Pediatric Oncology”, “Histiocytic Disorders”, “Non-Hodgkin’s Lymphoma in Childhood and Adolescence” and “Acute Promyelocytic Leukemia: A Clinical Guide” textbooks, the Principal Investigator of the International Rare Histiocytic Disorders Registry (IRHDR) and the Canadian National coordinator of the LCH-IV Trial.
He is one of the founding members of the North American Histiocytosis Consortium (NACHO), Chair of the NACHO-Rare Histiocytosis Working Group, as well as a member of the NACHO-CNS-LCH and LCH working groups. Dr. Abla has given several international presentations and co-authored more than 150 publications and book chapters focused on pediatric histiocytoses and leukemia/lymphoma, as well as supportive care in pediatric oncology.
